Saturday, February 27, 2010

PROFIT AT ABBOTT MISSES ANALYSTS? FORECASTS



The pharmaceutical company?s profit was hurt by an acquisition and a loss of exclusivity on the drug Depakote.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)